IRC8 Antibody

What is IRC8 and why are antibodies against it important for research?

IRC8 (YJL051W) is an uncharacterized protein in Saccharomyces cerevisiae that undergoes extensive post-translational modifications, particularly phosphorylation at multiple sites . Antibodies against IRC8 are crucial research tools that enable detection, localization, and quantification of this protein in yeast models. These antibodies facilitate investigations into cellular processes, stress responses, and metabolic pathways where IRC8 may play important regulatory roles. Additionally, IRC8 antibodies can be instrumental in studying how post-translational modifications like phosphorylation (detected at at least 23 different sites) and ubiquitination (observed at positions K163, K177, and K241) affect protein function and interactions .

How do I select the appropriate IRC8 antibody for my yeast research?

Selection of an IRC8 antibody should be guided by your specific experimental requirements and the particular epitope of interest. Consider the following methodological approach:

• Target specificity: Select antibodies raised against specific regions of IRC8, particularly those containing key post-translational modification sites (e.g., S228, which has the highest phosphorylation score) .

• Application compatibility: Ensure the antibody has been validated for your intended application (e.g., Western blotting, immunoprecipitation, or immunohistochemistry).

• Host species considerations: Choose an antibody raised in a species that minimizes cross-reactivity with other components in your experimental system.

• Validation status: Review published literature or manufacturer data showing the antibody's specificity and performance in contexts similar to your research design.

For yeast-specific applications, polyclonal antibodies may offer advantages for detecting native protein conformations, while monoclonal antibodies provide greater specificity for particular epitopes or modified forms of IRC8.

How can I optimize immunohistochemistry protocols using IRC8 antibodies?

Optimizing immunohistochemistry (IHC) protocols for IRC8 detection requires careful consideration of several parameters:

• Antigen retrieval: For paraffin-embedded yeast samples, heat-induced antigen retrieval is often necessary. Based on protocols used for similar antibody applications, use citrate buffer (pH 6.0) or EDTA buffer (pH 9.0) with heating to 95-100°C for 20-30 minutes .

• Antibody concentration: Begin with a concentration range of 1-30 μg/ml based on successful concentrations used for other yeast proteins. For example, similar antibody applications have shown optimal results at 28 μg/ml after heat-induced antigen retrieval .

• Incubation conditions: Primary antibody incubation is typically performed overnight at 4°C or for 1-2 hours at room temperature in a humidity chamber.

• Detection system: For yeast samples, a polymer-based detection system often provides better signal-to-noise ratio than avidin-biotin complexes, particularly for low-abundance proteins like IRC8.

• Controls: Always include positive controls (samples known to express IRC8) and negative controls (primary antibody omitted) to validate staining specificity.

The effectiveness of your protocol can be assessed by the signal-to-noise ratio and reproducibility of staining patterns across multiple samples.

What are the best approaches for quantifying IRC8 phosphorylation states using antibodies?

Quantifying IRC8 phosphorylation states requires specialized methodologies given the protein's multiple phosphorylation sites :

• Phospho-specific antibodies: When available, use antibodies specifically raised against phosphorylated epitopes (e.g., phospho-S228, which has a higher phosphorylation score) .

• Sequential immunoprecipitation: First immunoprecipitate total IRC8 using a general IRC8 antibody, then probe with anti-phosphoserine/threonine antibodies.

• Phos-tag™ SDS-PAGE: This technique can separate phosphorylated from non-phosphorylated forms based on mobility shifts, followed by Western blotting with IRC8 antibodies.

• Mass spectrometry validation: After immunoprecipitation with IRC8 antibodies, use mass spectrometry to identify and quantify specific phosphorylation sites.

A typical workflow involves:

• Sample preparation under phosphatase inhibitor protection

• Immunoprecipitation of IRC8

• Separation of phosphorylated forms

• Detection and quantification using antibodies or mass spectrometry

This approach enables tracking phosphorylation changes across different experimental conditions or genetic backgrounds.

How can IRC8 antibodies be applied in chromatin immunoprecipitation (ChIP) experiments?

While IRC8 is not a known transcription factor, investigating its potential nuclear localization or chromatin association requires a specialized ChIP protocol:

• Crosslinking optimization: For yeast cells, use 1% formaldehyde for 10-15 minutes at room temperature, as longer crosslinking may reduce efficiency.

• Sonication parameters: Optimize sonication conditions to generate DNA fragments of 200-500 bp (typically 10-15 cycles of 30 seconds on/30 seconds off at 40% amplitude).

• Antibody selection: Choose IRC8 antibodies with demonstrated nuclear protein detection capability and minimal background binding.

• Immunoprecipitation conditions: Pre-clear chromatin with protein A/G beads before adding 2-5 μg of IRC8 antibody per ChIP reaction.

• Controls: Include a non-specific IgG control and input samples at each step. If possible, use an IRC8 deletion strain as a negative control.

• Data validation: Confirm findings using alternative methods such as DamID or CUT&RUN, which may offer higher sensitivity for detecting transient chromatin interactions.

For quantitative analysis, normalize ChIP-qPCR data to input DNA and the IgG control to account for background and sampling variation.

What approaches can be used to investigate IRC8 protein-protein interactions using antibodies?

Investigating IRC8 protein-protein interactions requires careful experimental design due to its uncharacterized nature:

• Co-immunoprecipitation (Co-IP): Use IRC8 antibodies covalently linked to beads (to prevent antibody contamination in eluted samples) for pull-down experiments, followed by mass spectrometry to identify interacting partners.

• Proximity ligation assay (PLA): This technique allows visualization of protein interactions in situ using pairs of antibodies against IRC8 and potential interacting partners.

• Bimolecular fluorescence complementation (BiFC): While not directly using antibodies, this technique complements antibody-based methods by confirming interactions identified through Co-IP.

• Yeast two-hybrid validation: Interactions identified using antibody-based methods can be validated using yeast two-hybrid systems with IRC8 as bait.

When planning these experiments, consider that IRC8's extensive post-translational modifications may regulate its interaction network . Therefore, analyzing interactions under different conditions (e.g., cell cycle stages or stress responses) might reveal functionally significant dynamic associations.

How can I verify the specificity of my IRC8 antibody?

Verifying antibody specificity is critical for reliable research outcomes:

• Genetic controls: The most definitive control is testing the antibody against samples from IRC8 deletion strains, which should show no signal.

• Peptide competition assay: Pre-incubate the antibody with excess synthetic peptide containing the target epitope; this should abolish specific binding.

• Multiple antibody validation: Use at least two different antibodies targeting distinct epitopes of IRC8; concordant results increase confidence in specificity.

• Western blot profile analysis: A specific antibody should recognize a band of the expected molecular weight (~65 kDa for IRC8) with minimal additional bands.

• Mass spectrometry confirmation: After immunoprecipitation, confirm the identity of the pulled-down protein using mass spectrometry.

Each of these approaches addresses different aspects of specificity, and combining multiple methods provides the most robust validation.

Why might I observe inconsistent results with IRC8 antibodies in different experimental conditions?

Inconsistency in IRC8 antibody performance can stem from several factors:

• Post-translational modifications: IRC8 undergoes extensive phosphorylation and ubiquitination that may mask antibody epitopes under certain conditions . The table below shows key modification sites that might affect antibody binding:

• Protein conformation changes: Environmental conditions or experimental buffers may alter IRC8's conformation, affecting epitope accessibility.

• Expression level variations: IRC8 expression levels may vary significantly across growth phases or stress conditions.

• Fixation effects: For immunohistochemistry applications, different fixation methods can dramatically affect epitope preservation and accessibility .

• Antibody lot variation: Manufacturing variations between antibody lots can lead to differences in specificity and sensitivity.

To address these challenges, standardize your experimental conditions, document antibody lot numbers, and include appropriate controls in each experiment.

How can IRC8 antibodies be adapted for advanced imaging techniques like super-resolution microscopy?

Adapting IRC8 antibodies for super-resolution microscopy requires special considerations:

• Direct fluorophore conjugation: For techniques like STORM or PALM, directly conjugate IRC8 antibodies with photoswitchable fluorophores (e.g., Alexa Fluor 647) to achieve high localization precision.

• Secondary antibody selection: For STED microscopy, use secondary antibodies conjugated with dyes having small Stokes shifts and high photostability (e.g., STAR RED or ATTO 647N).

• Dual-color applications: When co-localizing IRC8 with other proteins, select fluorophore pairs with minimal spectral overlap and similar brightness to enable accurate co-localization analysis.

• Sample preparation optimization: Super-resolution techniques require meticulous sample preparation. For yeast cells, use spheroplasting protocols that preserve cellular architecture while allowing antibody penetration.

• Quantitative validation: Validate localization patterns observed in super-resolution imaging using complementary approaches such as biochemical fractionation or proximity labeling techniques.

These adaptations enable visualization of IRC8 distribution with nanometer precision, potentially revealing previously undetectable spatial organization or colocalization patterns.

What are the considerations for developing phospho-specific IRC8 antibodies for studying its regulatory mechanisms?

Developing phospho-specific antibodies against IRC8 requires strategic planning due to its multiple phosphorylation sites :

• Epitope selection: Choose phosphorylation sites with high conservation and demonstrated biological relevance. Sites S228 (score 2) and S5, which have higher phosphorylation scores, would be primary candidates .

• Peptide design: Design phosphopeptides of 10-15 amino acids with the phosphorylated residue centrally positioned. Include a terminal cysteine for conjugation to carrier proteins if not present in the native sequence.

• Carrier protein selection: KLH (keyhole limpet hemocyanin) is typically preferred for rabbit immunizations due to its high immunogenicity.

• Purification strategy: Develop a two-step purification protocol:

  • Affinity purification using the non-phosphorylated peptide to remove antibodies recognizing the backbone

  • Positive selection using the phosphorylated peptide to isolate phospho-specific antibodies

• Validation requirements: Validate specificity using:

  • Western blots comparing phosphatase-treated versus untreated samples

  • Peptide competition assays with phospho and non-phospho peptides

  • Testing against mutant strains where the phosphorylation site is replaced with alanine

These phospho-specific antibodies would enable precise tracking of IRC8 phosphorylation dynamics under different environmental conditions or genetic backgrounds.

How can IRC8 antibodies be combined with mass spectrometry for comprehensive protein characterization?

Integrating IRC8 antibodies with mass spectrometry creates powerful analytical workflows:

• Immunoprecipitation-Mass Spectrometry (IP-MS): Use IRC8 antibodies to pull down the protein complex, followed by LC-MS/MS analysis to identify:

  • Post-translational modifications across the 23+ known modification sites

  • Interaction partners under different experimental conditions

  • Conformational changes through hydrogen-deuterium exchange MS

• Selected Reaction Monitoring (SRM): Develop SRM assays targeting IRC8 peptides (both modified and unmodified) for absolute quantification across experimental conditions.

• Parallel Reaction Monitoring (PRM): For higher specificity, use PRM to quantify specific proteoforms of IRC8 differing in their modification patterns.

• Top-down proteomics: Analyze intact IRC8 immunoprecipitated with antibodies to characterize combinations of modifications that occur simultaneously.

This integrated approach provides deeper insights into IRC8 function than either technique alone, revealing both the identity and stoichiometry of modifications across different cellular contexts.

What are the best practices for using IRC8 antibodies in multiplexed immunoassays?

Implementing IRC8 antibodies in multiplexed immunoassays requires careful optimization:

• Antibody compatibility assessment: Test for cross-reactivity between IRC8 antibodies and other antibodies in your multiplex panel. This can be done through sequential staining controls where each antibody is omitted in turn.

• Signal separation strategies:

  • For fluorescence-based multiplexing, select fluorophores with minimal spectral overlap

  • For chromogenic multiplexing, use differentiable chromogens and optimize deposition order

• Sample preparation standardization: Develop consistent processing protocols that preserve all target epitopes simultaneously.

• Data normalization approach: Use internal reference proteins for normalization across samples and experiments.

• Validation requirements: Validate multiplexed results against single-plex measurements to ensure no interference between detection systems.

These practices ensure reliable simultaneous detection of IRC8 alongside other proteins of interest, enabling complex pathway analyses or spatial relationship studies with minimal sample consumption.